- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
右美托咪定对重症创伤患者应激反应和生活质量影响
右美托咪定对重症创伤患者应激反应和生活质量影响
摘 要 目的:探讨右美托咪定对ICU重症创伤患者应激反应和生活质量的影响。方法:按照进入ICU的次序将80例患者随机分为右美托咪定组(DEX组)和咪达唑仑组(对照组)。两组患者分别在给药前(T0)和给药后0.5 h(T1)、2 h(T2)、4 h(T3)和12 h(T4)抽取静脉血测定COR、GAS的含量,监测MAP、HR、SpO2和镇静评分的变化,记录不良反应及住院时间。结果:DEX组患者在T1、T2、T3、T4时间点的COR、GAS、HR、MAP较T0时下降明显,且均低于对照组(P0.05); SpO2优于对照组,而不良反应及住院时间均低于对照组(P0.05)。结论:右美托咪定能够降低ICU重症创伤患者应激反应,保证优良的镇静,减少住院时间,不良反应少,有利于改善患者的生活质量。
关键词 右美托咪定 重症创伤 应激反应 生活质量
中图分类号:R971.3; R641 文献标识码:B 文章编号:1006-1533(2018)03-0029-04
Effects of dexmedetomidine on stress response and quality of life in patients with severe trauma
SHAO Changchun*, ZHOU Yongqin, SONG Fangqiang
(The Central People’s Hospital of Tengzhou, Tengzhou 277500, China)
ABSTRACT Objective: To investigate the effects of dexmedetomidine on stress response and quality of life in patients with severe trauma. Methods: A total of 80 patients were randomized into a dexmedetomidine group (DEX group) and a midazolam group (control group) based on the order of their entry into the ICU. The levels of plasma cortisol (COR) and gastrin(GAS), mean arterial pressure (MAP), heart rate (HR), blood oxygen saturation (SpO2) and sedation scores in all patients were measured before treatment (T0) and at 0.5 h (T1), 2 h (T2), 4 h (T3), 12 h (T4) after treatment. The occurrence of adverse reactions in patients and their stay at ICU were recorded. Results: The levels of COR, GAS and HR in the DEX group decreased at T1, T2, T3 and T4 compared with T0 and furthermore were significantly lower than those in the control group (P0.05). Adverse reactions and the time for stay at ICU were less in the DEX group than in the control group (P0.05). Conclusion: Dexmedetomidine can reduce stress response of patients with severe trauma, the occurrence of adverse reactions and the stay at ICU and ensure the excellent sedation, which are of benefit to the improvement of the quality of life of patients.
KEY WORDS dexmedetomidine; severe trauma; stress response; quality of life
重?Y医学科(intensive
文档评论(0)